#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14042	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2059	675.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1407	1407	C	774	C	736	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14042	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2059	675.3	0	HET	.	.	.	C451T	.	451	451	C	674	674	C	767	C,T	381,343	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14042	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2059	675.3	0	HET	.	.	.	C207T,A	.	207	207	C	430	430	C	793	C,T,A	567,168,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25270	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3422	734.1	0	.	n	.	0	T695C	SNP	695	695	T	963	963	C	748	C,T	697,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25270	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3422	734.1	0	.	n	.	0	A1638G	SNP	1638	1638	A	1906	1906	G	832	G,A	788,5	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25270	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3422	734.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2239	2239	C	746	C	683	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25270	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3422	734.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2313	2313	A	761	A	727	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25270	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3422	734.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2865	2865	C	811	C	761	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1918	folP	855	855	100.0	folP.l15.c4.ctg.1	1519	125.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1006	1008	AGC	209;210;209	A;G;C	195;194;193	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5318	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3396	156.0	1	SNP	p	S91F	1	.	.	271	273	TTC	574	576	TTC	190;188;188	T;T;C	178;174;171	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5318	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3396	156.0	1	SNP	p	D95G	1	.	.	283	285	GGC	586	588	GGC	180;177;177	G;G;C	166;162;165	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5318	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3396	156.0	1	SNP	p	G95N	0	.	.	283	285	GGC	586	588	GGC	180;177;177	G;G;C	166;162;165	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1532	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1295	117.7	1	SNP	p	G45D	0	.	.	133	135	GGC	472	474	GGC	197;196;201	G;G;C	190;187;194	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	852	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1009	84.0	0	.	n	.	0	A197.	DEL	197	197	A	608	608	A	218	A	207	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4848	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3026	159.5	1	SNP	p	D86N	0	.	.	256	258	GAC	542	544	GAC	173;172;171	G;A;C	164;161;162	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4848	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3026	159.5	1	SNP	p	R87W	0	.	.	259	261	CGT	545	547	CGT	172;171;169	C,A;G;T	161,1;159;158	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4848	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3026	159.5	1	SNP	p	R87I	0	.	.	259	261	CGT	545	547	CGT	172;171;169	C,A;G;T	161,1;159;158	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4848	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3026	159.5	1	SNP	p	S87R	1	.	.	259	261	CGT	545	547	CGT	172;171;169	C,A;G;T	161,1;159;158	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4848	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3026	159.5	1	SNP	p	S88P	0	.	.	262	264	TCC	548	550	TCC	168;171;169	T;C;C	160;162;161	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4248	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2576	163.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1518	1520	GGC	222;222;221	G;G;C	207;207;204	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3888	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2348	164.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1192	1194	GCC	205;208;211	G;C;C	191;197;201	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3888	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2348	164.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1195	1197	ATG	213;213;212	A;T;G	201;202;200	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3888	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2348	164.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1207	1209	ACC	223;219;219	A;C;C	205;203;204	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3888	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2348	164.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1207	1209	ACC	223;219;219	A;C;C	205;203;204	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3888	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2348	164.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1708	1710	ACC	224;227;227	A;C;C	207;213;211	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3888	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2348	164.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1762	1764	GCG	220;222;223	G;C;G	208;210;208	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3888	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2348	164.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1762	1764	GCG	220;222;223	G;C;G	208;210;208	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3888	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2348	164.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1885	1887	GGT	173;171;172	G;G;T,C	156;154;153,2	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3888	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2348	164.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1894	1896	AGC	169;167;166	A,G;G;C	150,2;151;149	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3888	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2348	164.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1912	1914	CCG	145;149;149	C,G;C,T;G	114,4;116,2;123	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5272	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3002	174.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1529	1531	CCG	203;202;201	C;C,T;G	184;188,1;185	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2192	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1916	113.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	554	554	C	137	C,T	128,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	270	porB1a	984	331	90.15	porB1a.l15.c30.ctg.2	367	22.1	0	.	p	.	0	H217N	NONSYN	649	651	CAT	56	58	AAT	7;8;8	A;A;T	6;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	270	porB1a	984	331	90.15	porB1a.l15.c30.ctg.2	367	22.1	0	.	p	.	0	D218N	NONSYN	652	654	GAT	59	61	AAT	8;8;8	A;A;T	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	270	porB1a	984	331	90.15	porB1a.l15.c30.ctg.2	367	22.1	0	.	p	.	0	V226A	NONSYN	676	678	GTA	83	85	GCA	10;11;11	G;C;A	10;11;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	270	porB1a	984	331	90.15	porB1a.l15.c30.ctg.2	367	22.1	0	.	p	.	0	.	MULTIPLE	700	702	ACT	106	108	GTA	9;9;9	G;T;A	9;9;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	270	porB1a	984	331	90.15	porB1a.l15.c30.ctg.2	367	22.1	0	.	p	.	0	N237fs	FSHIFT	709	709	A	115	115	A	8	A	8	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2622	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1675	155.5	1	SNP	p	G120K	1	.	.	358	360	AAG	687	689	AAG	239;239;242	A;A;G	221;223;222	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2622	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1675	155.5	1	SNP	p	A121N	1	.	.	361	363	AAC	690	692	AAC	244;239;239	A,G;A;C	224,1;222;223	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2622	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1675	155.5	1	SNP	p	N121D	0	.	.	361	363	AAC	690	692	AAC	244;239;239	A,G;A;C	224,1;222;223	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9644	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4918	195.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1052	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1054	99.2	1	SNP	p	V57M	1	.	.	169	171	ATG	566	568	ATG	204;204;205	A;T;G	199;194;196	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
